Cargando…
Differentiation therapy using low‐dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16‐RARA
Autores principales: | Li, He, Xiang, Xinrong, Ding, Hong, Yu, Jiang, Xu, Juan, Yuan, Ying, Wu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828242/ https://www.ncbi.nlm.nih.gov/pubmed/36169236 http://dx.doi.org/10.1111/bjh.18476 |
Ejemplares similares
-
Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia
por: Langabeer, Stephen E., et al.
Publicado: (2017) -
An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the ZBTB16::RARa Variant and Review of the Literature
por: Castelijn, Daan A.R., et al.
Publicado: (2023) -
A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia
por: Han, Sang Bong, et al.
Publicado: (2010) -
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
por: Dunn, William G., et al.
Publicado: (2021) -
Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)